See also this year's filing and all EDGAR filings for this company.
PDF Report 0001053369_2016_Elite_Pharmaceuticals_INC_NV.pdf
Logs
Graph
Absolute values for 0001053369, Elite Pharmaceuticals INC NV
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 12,330,684 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 6,381,774 |
| 2 | PropertyPlantAndEquipmentNet | 6,401,802 |
| 3 | remainder_Assets | 806,019 |
| 4 | LiabilitiesCurrent | 5,069,097 |
| 5 | LiabilitiesNoncurrent | 20,582,268 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 2,650,800 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,228,316 |
| 9 | ResearchAndDevelopmentExpense | 68,492,328 |
| 10 | remainder_Expenses | 3,630,641 |
| 11 | remainder_Revenues | 5,400,040 |
| 12 | remainder_NetIncome | -91,431,724 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,920,279 |
| 1 | Liabilities | 25,651,365 |
| 2 | Expenses | 78,002,085 |
| 3 | Revenues | 5,400,040 |
| 4 | StockholdersEquity | 268,914 |
| 5 | NetIncome | -164,033,769 |
| 6 | ComprehensiveNetIncome | -164,033,769 |
| 7 | BaseVar | 113,202,746 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -6.34 |
| 9 | EconomicCapitalRatio | 0.0567 |
Edgar->Model Mapping
Feature Distribution
Change over Time
